Abel De La Rosa
About
In The Last Decade
Abel De La Rosa
26 papers receiving 847 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 644
- Pathology and Forensic Medicine 315
- Epidemiology 135
- Pulmonary and Respiratory Medicine 120
- Infectious Diseases 112
Countries citing papers authored by Abel De La Rosa
This map shows the geographic impact of Abel De La Rosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel De La Rosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel De La Rosa more than expected).
Fields of papers citing papers by Abel De La Rosa
This network shows the impact of papers produced by Abel De La Rosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel De La Rosa. The network helps show where Abel De La Rosa may publish in the future.
Co-authorship network of co-authors of Abel De La Rosa
This figure shows the co-authorship network connecting the top 25 collaborators of Abel De La Rosa. A scholar is included among the top collaborators of Abel De La Rosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abel De La Rosa. Abel De La Rosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 41 | |
| 6 | Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination with Sofosbuvir in Naive Subjects with HCV Genotype 1 Short Title: Telaprevir & Sofosbuvir in HCV Genotype 1 | 2 |
| 7 | 43 | |
| 8 | 4 | |
| 9 | 4 | |
| 10 | 25 | |
| 11 | 8 | |
| 12 | 32 | |
| 13 | 25 | |
| 14 | 30 | |
| 15 | 38 | |
| 16 | 197 | |
| 17 | 9 | |
| 18 | 75 | |
| 19 | 34 | |
| 20 | 181 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.